Immediate Impact
65 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Understanding the complexity of p53 in a new era of tumor suppression
2024 Standout
Works of Aaron Park being referenced
MIRROS: A Randomized, Placebo-Controlled, Phase III Trial of Cytarabine ± Idasanutlin in Relapsed or Refractory Acute Myeloid Leukemia
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Aaron Park | 258 | 258 | 119 | 18 | 576 | |
| Nicolás Spegazzini | 250 | 238 | 217 | 26 | 696 | |
| Zhi‐Min Zhang | 163 | 174 | 76 | 18 | 518 | |
| Matthew P. Nelson | 319 | 262 | 207 | 36 | 735 | |
| Kevin Yeh | 336 | 169 | 119 | 24 | 588 | |
| Michael D. Schaeberle | 300 | 203 | 211 | 15 | 648 | |
| David P. Myers | 65 | 359 | 81 | 26 | 710 | |
| Saumya Tiwari | 130 | 92 | 142 | 30 | 516 | |
| Rohith Reddy | 458 | 268 | 188 | 25 | 645 | |
| D. J. Ellis | 55 | 99 | 116 | 19 | 663 | |
| Julien Pichette | 342 | 177 | 309 | 18 | 673 |
All Works
Login with ORCID to disown or claim papers
Loading papers...